Register Log-in Investor Type


16 Mar 2021
BioPharma Credit leads new $315m loan to Sebela

Biopharma Credit looking healthy

Biopharma Credit looking healthy – BioPharma Credit has published its annual report for the period ended 31 December 2020. Highlights are: NAV was fairly flat during the period, decreasing by $0.018 from $1.0217 to $1.0037 8.29 cents per share in total dividends during period, comfortably ahead of the target to distribute at least 7 cents per […]

16 Mar 2021

US Solar beats expectations, looks to expand

US Solar beats expectations, looks to expand – US Solar Fund has published results for the year ended 31 December 2020. The highlights are: NAV at 31 December 2020 of $194.2m. The NAV increased by US$1.3m from 30 June 2020, due to construction cost savings on the Milford project, strong operating performance, and discount rate reductions […]

16 Mar 2021

QuotedData’s morning briefing 16 March 2021

In QuotedData’s morning briefing 16 March 2021: Hipgnosis plans to publish additional financial information which will help investors understand the underlying performance of its portfolio of songs. At the moment, purchases of new songs distort the company’s income. We now know that the portfolio of songs held on 31 December 2020 would have produced total revenue […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…